2 unchanged sentences
Our common stock is quoted on the Nasdaq Global Select Market (“Nasdaq ” ), under the symbol “CDXS.”
−Removed: As of February 24, 2025, there were approximatel y 123 stockholders of record.
+Added: As of March 5, 2026, there were approximatel y 113 stockholders of record.
A substantially greater number of stockholders may be “street name” or beneficial holders, whose shares are held of record by banks, brokers and other financial institutions.
6 unchanged sentences
The information required by this item concerning securities authorized for issuance under equity compensation plans is incorporated by reference from the information that will be set forth in the Definitive Proxy Statement to be filed with the Securities and Exchange Commission in connection with the Annual Meeting of Stockholders to be held in 2026 (the “2026 Proxy Statement ” ).
−Removed: Stock Price Performance Graph
−Removed: The following tabular information and graph compare our total common stock return with the total return for (i) the Nasdaq Composite Index and (ii) the Nasdaq Biotechnology Total Return Index for the period December 31, 2019 through December 31, 2024.
−Removed: The figures represented below assume an investment of $100 in our common stock at the closing price on December 31, 2019 and in the Nasdaq Composite Index and the Nasdaq Biotechnology Total Return Index on December 31, 2019 and the reinvestment of dividends into shares of common stock.
−Removed: The comparisons in the table and graph are required by the SEC and are not intended to forecast or be indicative of possible future performance of our common stock.
−Removed: The tabular information and graph shall not be deemed “soliciting material ” or to be “filed ” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act or the Exchange Act.
−Removed: $100 investment in stock or index Ticker 2019 2020 2021 2022 2023 2024
−Removed: Codexis, Inc.
−Removed: CDXS $ 100.00 $ 136.52 $ 195.56 $ 29.14 $ 19.07 $ 29.83
−Removed: Nasdaq Composite Total Return XCMP $ 100.00 $ 144.92 $ 177.06 $ 119.45 $ 172.78 $ 223.87
−Removed: Nasdaq Biotechnology (Total Return) Index XNBI $ 100.00 $ 126.42 $ 126.45 $ 113.65 $ 118.87 $ 118.20
Unregistered Sales of Equity Securities and Use of Proceeds
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.